|
Jan 20, 2021
|
Dynavax Appoints Kelly MacDonald as Chief Financial Officer
|
|
|
Jan 07, 2021
|
Dynavax Announces Final Immunogenicity and Interim Safety Results from Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
|
|
|
Jan 06, 2021
|
Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
|
|
